Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery
BACKGROUND Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the...
Uloženo v:
| Vydáno v: | Cancer Ročník 121; číslo 18; s. 3230 - 3239 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
15.09.2015
|
| Témata: | |
| ISSN: | 0008-543X, 1097-0142 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | BACKGROUND
Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer.
METHODS
The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real‐time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electron microscopy, biochemical tests, and Western blot analysis.
RESULTS
Hsp60 was found to be increased in cancerous tissue, in which it was localized in the tumor cell plasma membrane, and in the interstitium associated with cells of the immune system, in which it was associated with exosomes liberated by tumor cells and, as such, circulated in the blood. An interesting finding was that these parameters returned to normal shortly after tumor removal.
CONCLUSIONS
The data from the current study suggested that Hsp60 is a good candidate for theranostics applied to patients with large bowel carcinoma and encourage similar research among patients with other tumors in which Hsp60 has been implicated. Cancer 2015;121:3230–3239. © 2015 American Cancer Society.
Heat shock protein 60 is a chaperonin involved in tumorigenesis but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors present evidence supporting the theory that heat shock protein 60 has potential as a biomarker as well as a therapeutic target in patients with colon cancer. |
|---|---|
| AbstractList | Heat shock protein 60 is a chaperonin involved in tumorigenesis but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors present evidence supporting the theory that heat shock protein 60 has potential as a biomarker as well as a therapeutic target in patients with colon cancer. BACKGROUNDHeat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer.METHODSThe authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real-time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electron microscopy, biochemical tests, and Western blot analysis.RESULTSHsp60 was found to be increased in cancerous tissue, in which it was localized in the tumor cell plasma membrane, and in the interstitium associated with cells of the immune system, in which it was associated with exosomes liberated by tumor cells and, as such, circulated in the blood. An interesting finding was that these parameters returned to normal shortly after tumor removal.CONCLUSIONSThe data from the current study suggested that Hsp60 is a good candidate for theranostics applied to patients with large bowel carcinoma and encourage similar research among patients with other tumors in which Hsp60 has been implicated. BACKGROUND Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer. METHODS The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real‐time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electron microscopy, biochemical tests, and Western blot analysis. RESULTS Hsp60 was found to be increased in cancerous tissue, in which it was localized in the tumor cell plasma membrane, and in the interstitium associated with cells of the immune system, in which it was associated with exosomes liberated by tumor cells and, as such, circulated in the blood. An interesting finding was that these parameters returned to normal shortly after tumor removal. CONCLUSIONS The data from the current study suggested that Hsp60 is a good candidate for theranostics applied to patients with large bowel carcinoma and encourage similar research among patients with other tumors in which Hsp60 has been implicated. Cancer 2015;121:3230–3239. © 2015 American Cancer Society. Heat shock protein 60 is a chaperonin involved in tumorigenesis but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors present evidence supporting the theory that heat shock protein 60 has potential as a biomarker as well as a therapeutic target in patients with colon cancer. Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and its value as a tumor biomarker has not been fully elucidated. In the current study, the authors presented evidence supporting the theory that Hsp60 has potential as a biomarker as well as a therapeutic target in patients with large bowel cancer. The authors studied a population of 97 subjects, including patients and controls. Immunomorphology, Western blot analysis, and quantitative real-time polymerase chain reaction were performed on tissue specimens. Exosomes were isolated from blood and characterized by electron microscopy, biochemical tests, and Western blot analysis. Hsp60 was found to be increased in cancerous tissue, in which it was localized in the tumor cell plasma membrane, and in the interstitium associated with cells of the immune system, in which it was associated with exosomes liberated by tumor cells and, as such, circulated in the blood. An interesting finding was that these parameters returned to normal shortly after tumor removal. The data from the current study suggested that Hsp60 is a good candidate for theranostics applied to patients with large bowel carcinoma and encourage similar research among patients with other tumors in which Hsp60 has been implicated. |
| Author | Modica, Giuseppe Rappa, Francesca Zummo, Giovanni Geraci, Girolamo Campanella, Claudia Barone, Rosario Fais, Stefano Sciumè, Carmelo David, Sabrina Conway de Macario, Everly Curcurù, Giuseppe Macario, Alberto J.L. Cappello, Francesco Caruso Bavisotto, Celeste Farina, Felicia Pitruzzella, Alessandro Marino Gammazza, Antonella Bucchieri, Fabio |
| Author_xml | – sequence: 1 givenname: Claudia surname: Campanella fullname: Campanella, Claudia organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 2 givenname: Francesca surname: Rappa fullname: Rappa, Francesca organization: University of Palermo – sequence: 3 givenname: Carmelo surname: Sciumè fullname: Sciumè, Carmelo organization: University of Palermo – sequence: 4 givenname: Antonella surname: Marino Gammazza fullname: Marino Gammazza, Antonella organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 5 givenname: Rosario surname: Barone fullname: Barone, Rosario organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 6 givenname: Fabio surname: Bucchieri fullname: Bucchieri, Fabio organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 7 givenname: Sabrina surname: David fullname: David, Sabrina organization: University of Palermo – sequence: 8 givenname: Giuseppe surname: Curcurù fullname: Curcurù, Giuseppe organization: University of Palermo – sequence: 9 givenname: Celeste surname: Caruso Bavisotto fullname: Caruso Bavisotto, Celeste organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 10 givenname: Alessandro surname: Pitruzzella fullname: Pitruzzella, Alessandro organization: Euro‐Mediterranean Institute of Science and Technology – sequence: 11 givenname: Girolamo surname: Geraci fullname: Geraci, Girolamo organization: University of Palermo – sequence: 12 givenname: Giuseppe surname: Modica fullname: Modica, Giuseppe organization: University of Palermo – sequence: 13 givenname: Felicia surname: Farina fullname: Farina, Felicia organization: University of Palermo – sequence: 14 givenname: Giovanni surname: Zummo fullname: Zummo, Giovanni organization: University of Palermo – sequence: 15 givenname: Stefano surname: Fais fullname: Fais, Stefano organization: National Institute of Health – sequence: 16 givenname: Everly surname: Conway de Macario fullname: Conway de Macario, Everly organization: Institute of Marine and Environmental Technology – sequence: 17 givenname: Alberto J.L. surname: Macario fullname: Macario, Alberto J.L. organization: Institute of Marine and Environmental Technology – sequence: 18 givenname: Francesco surname: Cappello fullname: Cappello, Francesco organization: Euro‐Mediterranean Institute of Science and Technology |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26060090$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU9r3DAQxUVJSTZ_Lv0AQcdScDryWpZ1DEvbFEILpYXchCSPE7WylEh20j30u1cbJ5dQehpm5vcG3rxDshdiQELeMDhjAPV7G2w6q2Uj5SuyYiBFBayp98gKALqKN-urA3KY88_Sipqv98lB3UILIGFF_lygnmi-ifYXvU1xQhdoC9TjPfpMSzO5nGekOvTUumRnrycXrin-jjmO-IjczKMO1Ot0jdTEB_TU6mAxUYNDTItWD1MZaLOT3yPNc4HT9pi8HrTPePJUj8iPjx--by6qy6-fPm_OLyvLgclKD9C0omFCosQOGm6F4KzrQHZ9WdSg67YxQ6uLp9502Eoz8HbdmaHnwnCxPiJvl7vF4t2MeVKjyxa91wHjnBUT5WsgOJcFPX1CZzNir26TG3XaqueXFQAWwKaYc8JBWTcVVzFMSTuvGKhdKmqXinpMpUjevZA8X_0nzBb4wXnc_odUmy-bb4vmL9zgnYM |
| CitedBy_id | crossref_primary_10_3389_fmolb_2022_939050 crossref_primary_10_3390_ijms19092626 crossref_primary_10_3390_app11062867 crossref_primary_10_3390_ijms20184507 crossref_primary_10_3390_ijms20215331 crossref_primary_10_3390_biomedicines9080931 crossref_primary_10_3390_brainsci8060110 crossref_primary_10_1007_s00109_024_02452_6 crossref_primary_10_3389_fcell_2024_1344705 crossref_primary_10_1186_s13045_022_01317_0 crossref_primary_10_1088_2516_1091_ac73c9 crossref_primary_10_3390_biomedicines7040078 crossref_primary_10_1007_s10735_023_10119_8 crossref_primary_10_3389_fimmu_2021_796493 crossref_primary_10_1007_s11033_022_07714_5 crossref_primary_10_1016_j_semcancer_2021_07_014 crossref_primary_10_3390_ijms21155432 crossref_primary_10_1016_j_semcancer_2021_09_010 crossref_primary_10_1016_j_biopha_2021_112074 crossref_primary_10_3390_app11031175 crossref_primary_10_1002_jcp_25511 crossref_primary_10_3390_ijms20020236 crossref_primary_10_1016_j_tranon_2018_03_010 crossref_primary_10_1007_s00432_023_04701_6 crossref_primary_10_3390_cancers15082403 crossref_primary_10_3390_ijms25021049 crossref_primary_10_1016_j_talanta_2024_126604 crossref_primary_10_1016_j_semcancer_2022_01_003 crossref_primary_10_4251_wjgo_v13_i11_1561 crossref_primary_10_3390_app10176009 crossref_primary_10_3390_ijms19092603 crossref_primary_10_3390_ijms25105483 crossref_primary_10_1016_j_cej_2025_159935 crossref_primary_10_3390_jcm9072038 crossref_primary_10_1002_jev2_12195 crossref_primary_10_3390_cells10040754 crossref_primary_10_1016_j_cellsig_2022_110413 crossref_primary_10_1016_j_jinorgbio_2017_02_004 crossref_primary_10_1080_14737159_2021_1954909 crossref_primary_10_1177_17588359211027825 crossref_primary_10_3390_brainsci14040331 crossref_primary_10_1016_j_semcancer_2022_01_011 crossref_primary_10_3389_fonc_2021_727317 crossref_primary_10_1038_s41598_021_87037_w crossref_primary_10_1016_j_addr_2022_114117 crossref_primary_10_1080_14756366_2017_1292263 crossref_primary_10_1016_j_canlet_2020_08_016 crossref_primary_10_1007_s10989_019_09942_z crossref_primary_10_2147_IJN_S239548 crossref_primary_10_1080_14737159_2017_1356230 crossref_primary_10_3389_fphar_2019_00026 crossref_primary_10_3390_cancers12103019 crossref_primary_10_3390_biology14091281 crossref_primary_10_1002_cbf_3622 crossref_primary_10_1016_j_bmc_2021_116129 crossref_primary_10_1038_s41388_024_03261_4 crossref_primary_10_1080_14796694_2025_2520150 crossref_primary_10_3390_ijms22094367 crossref_primary_10_1038_srep42016 crossref_primary_10_31083_j_fbl2803056 crossref_primary_10_1038_s41392_024_01888_z crossref_primary_10_1111_jcmm_13092 crossref_primary_10_3390_s23239432 crossref_primary_10_3390_ijms23169317 crossref_primary_10_1016_j_semcancer_2022_12_008 crossref_primary_10_1007_s11801_024_3109_2 crossref_primary_10_1007_s12094_022_02877_w crossref_primary_10_1016_j_cca_2018_09_007 crossref_primary_10_3390_cancers15112878 crossref_primary_10_1016_j_canlet_2020_01_033 crossref_primary_10_1007_s11357_021_00394_2 crossref_primary_10_15252_embj_2021109288 crossref_primary_10_3390_ijms18050946 crossref_primary_10_1016_j_ejps_2016_11_007 crossref_primary_10_1016_j_urolonc_2025_07_006 crossref_primary_10_1016_j_bbagen_2016_07_019 crossref_primary_10_1016_j_tips_2016_11_009 crossref_primary_10_3390_ijms21020661 crossref_primary_10_3390_ijms20020434 crossref_primary_10_1007_s12192_016_0721_5 crossref_primary_10_3390_cells11132071 crossref_primary_10_1038_s41416_019_0617_0 crossref_primary_10_1016_j_ejps_2016_09_010 crossref_primary_10_1016_j_bbcan_2017_06_005 crossref_primary_10_1080_1061186X_2021_1920025 crossref_primary_10_3892_mmr_2019_10467 crossref_primary_10_13105_wjma_v9_i1_12 crossref_primary_10_3389_fmolb_2020_00095 crossref_primary_10_3390_ijms20184496 crossref_primary_10_1016_j_addr_2021_05_025 crossref_primary_10_3390_app14020722 crossref_primary_10_3390_ijms22084196 crossref_primary_10_1080_14756366_2020_1754814 crossref_primary_10_1016_j_addr_2021_05_029 crossref_primary_10_3390_cells11111780 crossref_primary_10_3390_cancers12092566 crossref_primary_10_3390_cancers15041307 crossref_primary_10_3390_cancers15164052 crossref_primary_10_3389_fmed_2021_743476 crossref_primary_10_1016_j_tranon_2020_100995 crossref_primary_10_1016_j_ab_2019_02_013 crossref_primary_10_1016_j_tibs_2016_01_003 crossref_primary_10_1016_j_biopha_2021_111882 crossref_primary_10_3389_fonc_2021_675940 crossref_primary_10_1016_j_jconrel_2023_10_031 crossref_primary_10_1155_2020_4701868 crossref_primary_10_3390_app10196961 crossref_primary_10_3390_cancers15235693 |
| Cites_doi | 10.1111/j.1749-6632.2010.05187.x 10.4081/814 10.1016/j.addr.2010.07.009 10.1074/jbc.M504803200 10.1083/jcb.93.1.97 10.1517/14728222.2014.856417 10.1111/j.1742-4658.2011.08385.x 10.1371/journal.pone.0079686 10.1586/erm.13.15 10.1093/intimm/dxh267 10.4049/jimmunol.1101988 10.1002/cncr.22265 10.1038/nprot.2008.73 10.1002/prca.200600718 10.1016/j.tibs.2006.01.006 10.4049/jimmunol.179.8.5523 10.2217/fon.13.106 10.1016/j.radonc.2010.03.024 10.1074/jbc.M112.340588 10.1371/journal.pone.0009247 10.1016/j.clinthera.2014.04.019 10.1084/jem.20011624 10.1053/j.gastro.2005.03.045 10.1097/DCR.0000000000000011 10.1097/PAI.0b013e3182118e5f 10.1371/journal.pone.0042008 10.1016/j.addr.2012.06.014 10.2217/bmm.13.63 10.1007/s12192-010-0196-8 10.1371/journal.pone.0028200 10.1016/S1470-2045(05)70393-4 10.1196/annals.1391.019 10.3109/02656736.2013.814809 10.1186/1471-2407-5-139 10.3109/02656736.2011.564598 10.1074/jbc.M702777200 10.1002/cncr.22278 10.1007/s12192-013-0460-9 |
| ContentType | Journal Article |
| Copyright | 2015 American Cancer Society 2015 American Cancer Society. |
| Copyright_xml | – notice: 2015 American Cancer Society – notice: 2015 American Cancer Society. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U8 7X8 C1K JXQ |
| DOI | 10.1002/cncr.29499 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management Toxline |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management |
| DatabaseTitleList | CrossRef TOXLINE MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-0142 |
| EndPage | 3239 |
| ExternalDocumentID | 26060090 10_1002_cncr_29499 CNCR29499 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: European Regional Development Fund – fundername: The Italian National Operational Programme for Research and Competitiveness 2007‐2013 funderid: project code: PONa3_00210 |
| GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AAQOH AARRQ AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGXDD AGYGG AIDQK AIDYY CITATION O8X CGR CUY CVF ECM EIF NPM 7U8 7X8 C1K JXQ |
| ID | FETCH-LOGICAL-c5019-af04674179e9e8045c775188098d46720a264bf6a009db8e69bf5638bfd57b573 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 142 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000360763200011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-543X |
| IngestDate | Sun Nov 09 10:21:03 EST 2025 Thu Apr 03 07:08:04 EDT 2025 Sat Nov 29 07:17:12 EST 2025 Tue Nov 18 21:47:05 EST 2025 Wed Jan 22 16:32:27 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 18 |
| Keywords | heat shock protein 60 (Hsp60) plasma cell membrane natural killer cells macrophages colon adenocarcinoma exosomes theranostics |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 American Cancer Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5019-af04674179e9e8045c775188098d46720a264bf6a009db8e69bf5638bfd57b573 |
| Notes | The first 3 authors contributed equally to this work. We thank Claudio Tripodo, MD, for the gift of anti‐CD57 antibody. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.29499 |
| PMID | 26060090 |
| PQID | 1709707559 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1709707559 pubmed_primary_26060090 crossref_citationtrail_10_1002_cncr_29499 crossref_primary_10_1002_cncr_29499 wiley_primary_10_1002_cncr_29499_CNCR29499 |
| PublicationCentury | 2000 |
| PublicationDate | September 15, 2015 |
| PublicationDateYYYYMMDD | 2015-09-15 |
| PublicationDate_xml | – month: 09 year: 2015 text: September 15, 2015 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cancer |
| PublicationTitleAlternate | Cancer |
| PublicationYear | 2015 |
| References | 2013; 29 2011; 278 2006; 31 2012; 287 2010; 15 2012; 189 2007; 282 1982; 93 2013; 65 2002; 195 2008; 3 2013; 7 2010; 1197 2013; 8 2011; 19 2011; 6 2012; 32 2010; 62 2013; 9 2005; 280 2007; 179 2013; 13 2005; 128 2007; 1113 2005; 5 2003; 47 2014; 36 2005; 6 2014; 57 2014; 19 2014; 18 2012; 7 2007; 1 2011; 27 2006; 107 2010; 5 2005; 17 2010; 95 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 Rappa F (e_1_2_7_6_1) 2012; 32 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 |
| References_xml | – volume: 36 start-page: 820 year: 2014 end-page: 829 article-title: Exosomes as immunotheranostic nanoparticles publication-title: Clin Ther. – volume: 107 start-page: 2417 year: 2006 end-page: 2424 article-title: Hsp60 and Hsp10 down‐regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease publication-title: Cancer. – volume: 189 start-page: 2833 year: 2012 end-page: 2842 article-title: Immune surveillance properties of human NK cell‐derived exosomes publication-title: J Immunol. – volume: 18 start-page: 185 year: 2014 end-page: 208 article-title: Hsp60 chaperonopathies and chaperonotherapy: targets and agents publication-title: Expert Opin Ther Targets. – volume: 280 start-page: 28917 year: 2005 end-page: 28926 article-title: Extracellular trafficking of myocilin in human trabecular meshwork cells publication-title: J Biol Chem. – volume: 7 start-page: e42008 year: 2012 article-title: The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane‐associated stages and Golgi and exosomal protein‐trafficking modalities publication-title: PLoS One. – volume: 1113 start-page: 28 year: 2007 end-page: 39 article-title: Extracellular heat shock proteins in cell signaling and immunity publication-title: Ann N Y Acad Sci. – volume: 15 start-page: 877 year: 2010 end-page: 884 article-title: Hsp60 and Hsp10 increase in colon mucosa of Crohn's disease and ulcerative colitis publication-title: Cell Stress Chaperones. – volume: 13 start-page: 257 year: 2013 end-page: 269 article-title: Nanotheranostics for personalized medicine publication-title: Expert Rev Mol Diagn. – volume: 278 start-page: 4845 year: 2011 end-page: 4859 article-title: Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer publication-title: FEBS J. – volume: 19 start-page: 343 year: 2014 end-page: 353 article-title: Elevated blood Hsp60, its structural similarities and cross‐reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis publication-title: Cell Stress Chaperones. – volume: 95 start-page: 350 year: 2010 end-page: 358 article-title: Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer publication-title: Radiother Oncol. – volume: 179 start-page: 5523 year: 2007 end-page: 5533 article-title: The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands publication-title: J Immunol. – volume: 6 start-page: 816 year: 2005 article-title: Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis publication-title: Lancet Oncol. – volume: 47 start-page: 105 year: 2003 end-page: 110 article-title: 60kDa chaperonin (HSP60) is over‐expressed during colorectal carcinogenesis publication-title: Eur J Histochem. – volume: 6 start-page: e28200 year: 2011 article-title: Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis publication-title: PLoS One. – volume: 57 start-page: 64 year: 2014 end-page: 69 article-title: Systematic review of internet patient information on colorectal cancer surgery publication-title: Dis Colon Rectum. – volume: 9 start-page: 1573 year: 2013 end-page: 1586 article-title: HSF1‐mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics publication-title: Future Oncol. – volume: 282 start-page: 31289 year: 2007 end-page: 31301 article-title: Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro‐apoptotic or pro‐survival functions involve differential interactions with caspase‐3 publication-title: J Biol Chem. – volume: 93 start-page: 97 year: 1982 end-page: 102 article-title: Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum publication-title: J Cell Biol. – volume: 27 start-page: 604 year: 2011 end-page: 611 article-title: Induction of a tumour‐specific CTL response by exosomes isolated from heat‐treated malignant ascites of gastric cancer patients publication-title: Int J Hyperthermia. – volume: 62 start-page: 1064 year: 2010 end-page: 1079 article-title: Nanoparticle‐based theranostic agents publication-title: Adv Drug Deliv Rev. – volume: 31 start-page: 164 year: 2006 end-page: 172 article-title: Heat shock proteins in cancer: chaperones of tumorigenesis publication-title: Trends Biochem Sci. – volume: 1 start-page: 336 year: 2007 end-page: 342 article-title: Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer publication-title: Proteomics Clin Appl. – volume: 128 start-page: 1796 year: 2005 end-page: 1804 article-title: Human colorectal cancer cells induce T cell death through release of pro‐apoptotic microvesicles: role in immune escape publication-title: Gastroenterology. – volume: 3 start-page: 1101 year: 2008 end-page: 1108 article-title: Analyzing real‐time PCR data by the comparative C(T) method publication-title: Nat Protoc. – volume: 65 start-page: 357 year: 2013 end-page: 367 article-title: Exosomes as nano‐theranostic delivery platforms for gene therapy publication-title: Adv Drug Deliv Rev. – volume: 17 start-page: 879 year: 2005 end-page: 887 article-title: Exosomal‐like vesicles are present in human blood plasma publication-title: Int Immunol. – volume: 1197 start-page: 85 year: 2010 end-page: 93 article-title: Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems publication-title: Ann N Y Acad Sci. – volume: 5 start-page: e9247 year: 2010 article-title: Hsp60 is actively secreted by human tumor cells publication-title: PLoS One. – volume: 287 start-page: 15874 year: 2012 end-page: 15885 article-title: Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro publication-title: J Biol Chem. – volume: 5 start-page: 139 year: 2005 article-title: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase publication-title: BMC Cancer. – volume: 8 start-page: e79686 year: 2013 article-title: Endurance exercise and conjugated linoleic acid (CLA) supplementation up‐regulate CYP17A1 and stimulate testosterone biosynthesis publication-title: PLoS One. – volume: 107 start-page: 2352 year: 2006 end-page: 2360 article-title: Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer: a systematic review publication-title: Cancer. – volume: 195 start-page: 1303 year: 2002 end-page: 1316 article-title: Induction of lymphocyte apoptosis by tumor cell secretion of FASL‐bearing microvesicles publication-title: J Exp Med. – volume: 19 start-page: 552 year: 2011 end-page: 561 article-title: Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis publication-title: Appl Immunohistochem Mol Morphol. – volume: 32 start-page: 5139 year: 2012 end-page: 5150 article-title: HSP‐molecular chaperones in cancer biogenesis and tumor therapy: an overview publication-title: Anticancer Res. – volume: 7 start-page: 769 year: 2013 end-page: 778 article-title: Exosomes: the future of biomarkers in medicine publication-title: Biomark Med. – volume: 29 start-page: 436 year: 2013 end-page: 441 article-title: Constitutive expression and activation of stress response genes in cancer stem‐like cells/tumour initiating cells: potent targets for cancer stem cell therapy publication-title: Int J Hyperthermia. – ident: e_1_2_7_20_1 doi: 10.1111/j.1749-6632.2010.05187.x – ident: e_1_2_7_30_1 doi: 10.4081/814 – ident: e_1_2_7_38_1 doi: 10.1016/j.addr.2010.07.009 – ident: e_1_2_7_29_1 doi: 10.1074/jbc.M504803200 – ident: e_1_2_7_28_1 doi: 10.1083/jcb.93.1.97 – ident: e_1_2_7_5_1 doi: 10.1517/14728222.2014.856417 – ident: e_1_2_7_33_1 doi: 10.1111/j.1742-4658.2011.08385.x – ident: e_1_2_7_23_1 doi: 10.1371/journal.pone.0079686 – ident: e_1_2_7_12_1 doi: 10.1586/erm.13.15 – ident: e_1_2_7_26_1 doi: 10.1093/intimm/dxh267 – ident: e_1_2_7_16_1 doi: 10.4049/jimmunol.1101988 – ident: e_1_2_7_8_1 doi: 10.1002/cncr.22265 – ident: e_1_2_7_24_1 doi: 10.1038/nprot.2008.73 – ident: e_1_2_7_32_1 doi: 10.1002/prca.200600718 – volume: 32 start-page: 5139 year: 2012 ident: e_1_2_7_6_1 article-title: HSP‐molecular chaperones in cancer biogenesis and tumor therapy: an overview publication-title: Anticancer Res. – ident: e_1_2_7_2_1 doi: 10.1016/j.tibs.2006.01.006 – ident: e_1_2_7_39_1 doi: 10.4049/jimmunol.179.8.5523 – ident: e_1_2_7_3_1 doi: 10.2217/fon.13.106 – ident: e_1_2_7_35_1 doi: 10.1016/j.radonc.2010.03.024 – ident: e_1_2_7_21_1 doi: 10.1074/jbc.M112.340588 – ident: e_1_2_7_17_1 doi: 10.1371/journal.pone.0009247 – ident: e_1_2_7_13_1 doi: 10.1016/j.clinthera.2014.04.019 – ident: e_1_2_7_14_1 doi: 10.1084/jem.20011624 – ident: e_1_2_7_15_1 doi: 10.1053/j.gastro.2005.03.045 – ident: e_1_2_7_10_1 doi: 10.1097/DCR.0000000000000011 – ident: e_1_2_7_22_1 doi: 10.1097/PAI.0b013e3182118e5f – ident: e_1_2_7_18_1 doi: 10.1371/journal.pone.0042008 – ident: e_1_2_7_37_1 doi: 10.1016/j.addr.2012.06.014 – ident: e_1_2_7_40_1 doi: 10.2217/bmm.13.63 – ident: e_1_2_7_34_1 doi: 10.1007/s12192-010-0196-8 – ident: e_1_2_7_25_1 doi: 10.1371/journal.pone.0028200 – ident: e_1_2_7_7_1 doi: 10.1016/S1470-2045(05)70393-4 – ident: e_1_2_7_19_1 doi: 10.1196/annals.1391.019 – ident: e_1_2_7_4_1 doi: 10.3109/02656736.2013.814809 – ident: e_1_2_7_31_1 doi: 10.1186/1471-2407-5-139 – ident: e_1_2_7_36_1 doi: 10.3109/02656736.2011.564598 – ident: e_1_2_7_9_1 doi: 10.1074/jbc.M702777200 – ident: e_1_2_7_11_1 doi: 10.1002/cncr.22278 – ident: e_1_2_7_27_1 doi: 10.1007/s12192-013-0460-9 |
| SSID | ssj0007253 |
| Score | 2.5362697 |
| Snippet | BACKGROUND
Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well... Heat shock protein 60 is a chaperonin involved in tumorigenesis but its participation in tumor development and progression is not well understood and its value... Heat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well understood and... BACKGROUNDHeat shock protein 60 (Hsp60) is a chaperonin involved in tumorigenesis, but its participation in tumor development and progression is not well... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3230 |
| SubjectTerms | Adenocarcinoma - metabolism Adenocarcinoma - pathology Adenocarcinoma - surgery Aged Aged, 80 and over Biomarkers, Tumor - analysis Blotting, Western Chaperonin 60 - analysis Chaperonin 60 - metabolism colon adenocarcinoma Colonic Neoplasms - metabolism Colonic Neoplasms - pathology Colonic Neoplasms - surgery Enzyme-Linked Immunosorbent Assay exosomes Exosomes - metabolism Female heat shock protein 60 (Hsp60) Humans Immunohistochemistry macrophages Male Middle Aged Mitochondrial Proteins - analysis Mitochondrial Proteins - metabolism natural killer cells plasma cell membrane Real-Time Polymerase Chain Reaction theranostics |
| Title | Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.29499 https://www.ncbi.nlm.nih.gov/pubmed/26060090 https://www.proquest.com/docview/1709707559 |
| Volume | 121 |
| WOSCitedRecordID | wos000360763200011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1097-0142 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1097-0142 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: WIN dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9RAEB5qLeKL2lr1_HGstC8W0iab7O0GfJHT4wo1lNLSvIXdzUYLMZGkp774vzu7yeU4KoXSt4TMJGFnZ_ZLdvf7APaDoKBcRzkiNz7xIsoDT-mce0pyLqlR6CSc2ARPEpGm8ekGfFzuhen4IYYfbjYzXL22CS5Ve7QiDdWVbg6p5VbBAhxELisvj5OhDHPaU1D6wmNRmA7cpPRo5bo-Gt2AmOuI1Q05s6f3e9ln8KSHmuRT1ze2YcNUO_Doaz-Z_hz-zrEOk_Y7VkTi6BquKjLxSWmXEbUET65dUIiscqKvGu2EvqpvxPyp2_qHcSZO4o-Udjk5UfVvUxJtu1FDlEE03Pk6GXIiVek4xknbbcTehYvZl_Pp3OvVGDzNEAd6svCtMgkmsImNQCSoOXdsbrHI8QL1JWIrVUwkorZcCTOJVcEwu1WRM64YD1_AZlVX5hWQmMWRZSoUppCR1lxEYWF8QxF6hFLRcAQfllHJdE9VbhUzyqwjWaaZbc_MtecI9gbbnx1Bx3-t3i-Dm2H-2EkRWZl60WYB92OOuImhzcsu6sN98FsP8WDsj-DABfeWB2TTZHrmjl7fxfgNPEYExuwClIC9hc3rZmHewZb-hRFuxvCAp2IMDz-fzS5Oxq57_wM2XPty |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB6VXUS5tLzZtoARXEAKJE68To7VltUilhVCIO0tsh0HkNIEJdD20v_esZMNQkVIiFuijJPI8_Bne_wNwL7npZSrIEHkxvtOQLnnSJVwRwrOBdUSG4W22ASfTMLpNLpocnPMWZiaH6JdcDOeYeO1cXCzIH38xBqqclUeUUOuMgfdAO2IdaD743J4PW5DMacNDaUbOizwpy0_KT1-av18RPoPZj5HrXbYGX5-5w8vwacGb5LvtYEswwedr8DCebOjvgp_RxiMSXWLYZFYzoa7nPRdkplcoorgzYPVDBF5QtRdqWy1r_yG6D9FVfzUVsTW-SOZySknsvitM6KMLZVEaoTEdVtbi5wImVmicVLVp7HX4Hp4cjUYOU1JBkcxBIOOSF1TngS9WEc6RDioOLeUblGY4APqCgRYMu0LhG6JDHU_kilD1cg0YVwy7q9DJy9yvQkkYlFg6ApDnYpAKR4GfqpdTRF_-EJSvwcHM7XEquErN2UzsrhmWqax6c_Y9mcP9lrZ-5ql40Wp3Zl2Y3QiszMicl08VrHH3YgjeGIos1GrvX0PTvgQFEZuDw6tdl_5QDyYDC7t1Ze3CO_Ax9HV-Tgen07OvsIiQjJmMlI89g06D-Wj3oJ59Qu1XW439v0PHJj-Ng |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS90wFD84FdnL_Nh014-Zsb04qLZp0zSPcvWi6C4iE-5bSdJUha6V1q8X_3dP0loRRRh7a-lJW3JyTn5tTn4_gJ9BkFOuowyRG4-9iPLAUzrjnpKcS2oUNkqc2AQfj5PJRJx0tTl2L0zLD9H_cLOR4fK1DXBzleU7z6yhutT1NrXkKh9gJmIixric2TsdnR33qZjTjobSTzwWhZOen5TuPLd-OSO9gpkvUaubdkbz__nCC_Cpw5tktx0gizBlyiWY-92tqH-GhwNMxqS5wLRIHGfDZUlinxS2lqgheHLtPENkmRF9WWun9lWeE3NfNdVf40yczh8pbE05UdWdKYi2Y6kmyiAkbts6LXIiVeGIxknT7sb-Amej_T_DA6-TZPA0QzDoydy38iQYxUaYBOGg5txRuokkwwvUlwiwVB5LhG6ZSkwsVM4wxFWeMa4YD5dhuqxK8xWIYCKydIWJyWWkNU-iMDe-oYg_QqloOICtJ7ekuuMrt7IZRdoyLdPU9mfq-nMAP3rbq5al402r70_eTTGI7MqILE1106QB9wVH8MTQZqV1e38f_OBDUCj8Afxy3n3nAelwPDx1R6v_YrwJcyd7o_T4cHy0Bh8RkTFbkBKwdZi-rm_MBszqW3R2_a0b3o-q-_2x |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heat+shock+protein+60+levels+in+tissue+and+circulating+exosomes+in+human+large+bowel+cancer+before+and+after+ablative+surgery&rft.jtitle=Cancer&rft.au=Campanella%2C+Claudia&rft.au=Rappa%2C+Francesca&rft.au=Scium%C3%A8%2C+Carmelo&rft.au=Marino+Gammazza%2C+Antonella&rft.date=2015-09-15&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=121&rft.issue=18&rft.spage=3230&rft.epage=3239&rft_id=info:doi/10.1002%2Fcncr.29499&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_cncr_29499 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |